FDA Advised to Add 'Black Box' Warnings to Ritalin, Other Stimulants

An advisory panel to the federal Food and Drug Administration (FDA) said yesterday it is recommending that the FDA require manufacturers of widely prescribed stimulants such as Ritalin, Adderall, and Concerta to place the most serious type of warning on the drugs, to indicate they may increase the risk of strokes and cardiac arrhythmias in children and adults.

Read alert at: http://www.healthinschools.org/2006/feb10b_alert.asp

For information, resources and practical strategies on autism please visit: www.AutismConcepts.com.